No Pharma Money
News & Reports
News October 28, 2019

The Week in Review in Prescription Drug Pricing

By P4ADNow Team

Will Washington take a swing at lowering drug prices? Senate, House, and Administration reforms would be a home run for patients.

1. The Plot Thickens

  • A new report uncovered an elaborate campaign complete with celebrity cops, seven-figure ads, and a shady consulting firm — all funded by PhRMA. — (Bloomberg)

2. A Win for Patients

  • The House Ways & Means Committee took a significant step in the right direction by voting to advance HR 3, legislation that would lower drug prices for all Americans — regardless of insurance type. — (AP)

3. The Legacy of a Hero

  • America lost drug pricing hero Rep. Elijah Cummings. Now, House members are advancing a bill in his honor. — (Fierce Pharma)

4. Taxpayer drug development

  • Over the past decade, one in four new medicines benefitted from late-stage taxpayer-funded research, including clinical trials. Time for pharma to stop price gouging off of public science. — (British Medical Journal)

5. Big Momentum:

  • Patients are speaking out, and ideas and legislation are moving forward in the Senate and the House. — (P4ADN)

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.